In agreement with earlier reports, HMGA1 overexpression correlated significantly with poor overall survival and progression-free interval in multiple cancers including GBMLGG, LUAD, LIHC, KIRP, and PAAD [65,66,67,68]. Here, HMGA1 is linked to pancreatic adenocarcinoma.